Juan S. Farias

Juan S. Farias

Auto-generated profile, based on publicly available information

Juan S. Farias

Children’s Mercy Hospital

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2021 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Open access
PDF file
Rohit LoombaRohit Loomba
Rohit Loomba
EVEnrique G. Villarreal
Enrique G. Villarreal
JDJanhavi Dhargalkar
Janhavi Dhargalkar
JRJacqueline Rausa
Jacqueline Rausa
VDVincent Dorsey
Vincent Dorsey
SFSaul Flores
Saul Flores
What is known and objective Acute kidney injury (AKI) is a complication following surgery and has been associated with worsened patient outcomes. Providers have used agents that may confer a degree of renal protection in the perioperative stage. Such is the case of dexmedetomidine, a selective alpha-2 adrenergic agonist used in the intensive care unit (ICU) as a sedative agent. The primary objective of this meta-analysis was to characterize the use of dexmedetomidine and to evaluate its impact on renal markers and outcomes in patients after surgery. Methods A systematic review of manuscripts was performed to identify patients who received dexmedetomidine after surgery by searching the PubMed, Embase, and Cochrane databases. The following parameters were captured: blood urea nitrogen (BUN), serum creatinine, creatinine clearance, neutrophil gelatinase-associated lipoprotein (NGAL), cystatin C, urine output, duration of mechanical ventilation, ICU length of stay, AKI, need for dialysis, and mortality. Results and Discussion Nineteen studies with 3,395 patients were included in the analyses. The mean bolus and infusion dose of dexmedetomidine were 0.82 µg/kg and 0.54 mcg/kg/hr, respectively. There was a significant difference in creatinine clearance and NGAL in favour of the dexmedetomidine group. In addition, the dexmedetomidine group had a shorter ICU length of stay, and a lower risk of acute kidney injury and mortality compared to the control. There was no difference in the rest of the parameters. What is new and conclusion Dexmedetomidine appears to have postoperative renal protective effects. This is evidenced by lower NGAL levels and increased creatinine clearance in those who received dexmedetomidine. These effects are associated with decreases in ICU length of stay and risk of AKI and mortality.

14 May 2021 in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
Verified
Journal Article
Closed access
PDF file
RLRohit S Loomba
Rohit S Loomba
EVEnrique G Villarreal
Enrique G Villarreal
JFJuan S Farias
Juan S Farias
GAGaurav Aggarwal
Gaurav Aggarwal
SASaurabh Aggarwal
Saurabh Aggarwal
SFSaul Flores
Saul Flores
Background: There is limited information regarding the role of biomarker levels at predicting mortality in patients with the coronavirus disease (COVID-19) pandemic. The purpose of this study is to determine the differences in serum biomarker levels in adults with COVID-19 who survived hospitalization from those who did not. Methods: A comprehensive search was completed on PubMed, EMBASE and Cochrane libraries to identify studies of interest. Endpoints of interest were blood counts, hepatic function test, acute phase reactants, cytokines and cardiac biomarkers. Results: A total of 10 studies with 1584 patients were included in the pooled analyses. Biomarkers that were noted to be significantly higher in those who died from coronavirus disease included: white blood cell count, neutrophil count, C-reactive protein, high sensitivity C-reactive protein, procalcitonin, ferritin, D-dimer, interleukin-6, lactate dehydrogenase, creatine kinase, prothrombin time, aspartate aminotransferase, alanine aminotransferase, total bilirubin and creatinine. Lymphocyte count, platelet count and albumin were significantly lower in patients who died. Conclusion: This pooled analysis of 10 studies including 1584 patients identified significant differences in biomarkers on admission in patients who survived from those who did not. Further research is needed to develop risk stratification models to help with judicious use of limited health-care resources.

18 February 2022 in Journal of Pediatric Intensive Care
Verified
Journal Article
Closed access
PDF file
Rohit LoombaRohit Loomba
Rohit Loomba
JFJuan S. Farias
Juan S. Farias
EVEnrique G. Villarreal
Enrique G. Villarreal
SFSaul Flores
Saul Flores
The primary objective of this study was to determine if serum lactate level at the time of hospital admission can predict mortality in pediatric patients. A systematic review was conducted to identify studies that assessed the utility of serum lactate at the time of admission to predict mortality in pediatric patients. The areas under the curve from the receiver operator curve analyses were utilized to determine the pooled area under the curve. Additionally, standardized mean difference was compared between those who survived to discharge and those who did not. A total of 12 studies with 2,099 patients were included. Out of these, 357 (17%) experienced mortality. The pooled area under the curve for all patients was 0.74 (0.67–0.80, p < 0.01). The pooled analyses for all admissions were higher in those who experienced mortality (6.5 vs. 3.3 mmol/L) with a standardized mean difference of 2.60 (1.74–3.51, p < 0.01). The pooled area under the curve for cardiac surgery patients was 0.63 (0.53–0.72, p < 0.01). The levels for cardiac surgery patients were higher in those who experienced mortality (5.5 vs. 4.1 mmol/L) with a standardized mean difference of 1.80 (0.05–3.56, p = 0.04). Serum lactate at the time of admission can be valuable in identifying pediatric patients at greater risk for inpatient mortality. This remained the case when only cardiac surgery patients were included.

29 August 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
JFJuan S. Farias
Juan S. Farias
EVEnrique G. Villarreal
Enrique G. Villarreal
JDJanhavi Dhargalkar
Janhavi Dhargalkar
AKAlicia Kleinhans
Alicia Kleinhans
SFSaul Flores
Saul Flores
Rohit LoombaRohit Loomba
Rohit Loomba

18 November 2020 in International Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Rohit LoombaRohit Loomba
Rohit Loomba
EVEnrique G. Villarreal
Enrique G. Villarreal
JFJuan S. Farias
Juan S. Farias
RBRonald A. Bronicki
Ronald A. Bronicki
SFSaul Flores
Saul Flores
Introduction. Intensive care has played a pivotal role during the COVID-19 pandemic as many patients developed severe pulmonary complications. The availability of information in pediatric intensive care units (PICUs) remains limited. The purpose of this study is to characterize COVID-19 positive admissions (CPAs) in the United States and to determine factors that may impact those admissions. Materials and Methods. This is a retrospective cohort study using data from the COVID-19 Virtual Pediatric System (VPS) dashboard containing information regarding respiratory support and comorbidities for all CPAs between March and April 2020. The state-level data contained 13 different factors from population density, comorbid conditions, and social distancing score. The absolute CPA count was converted to frequency using the state’s population. Univariate and multivariate regression analyses were performed to assess the association between CPA frequency and admission endpoints. Results. A total of 205 CPAs were reported by 167 PICUs across 48 states. The estimated CPA frequency was 2.8 per million children in a one-month period. A total of 3,235 tests were conducted of which 6.3% were positive. Children above 11 years of age comprised 69.7% of the total cohort and 35.1% had moderated or severe comorbidities. The median duration of a CPA was 4.9 days (1.25–12.00 days). Out of the 1,132 total CPA days, 592 (52.2%) involved mechanical ventilation. The inpatient mortalities were 3 (1.4%). Multivariate analyses demonstrated an association between CPAs with greater population density (beta coefficient 0.01, ). Multivariate analyses also demonstrated an association between pediatric type 1 diabetes mellitus with increased CPA duration requiring advanced respiratory support (beta coefficient 5.1, ) and intubation (beta coefficient 4.6, ). Conclusions. Inpatient mortality during PICU CPAs is relatively low at 1.4%. CPA frequency seems to be impacted by population density. Type 1 DM appears to be associated with increased duration of HFNC and intubation. These factors should be included in future studies using patient-level data.

15 October 2021 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
FSFabio Savorgnan
Fabio Savorgnan
SFSaul Flores
Saul Flores
Rohit LoombaRohit Loomba
Rohit Loomba
PCPaul A. Checchia
Paul A. Checchia
RBRonald A. Bronicki
Ronald A. Bronicki
SASebastian Acosta
Sebastian Acosta